40 likes | 152 Views
PRISM-PLUS: Demographics of Patients With Diabetes. Patients Without Patients With Diabetes Diabetes (n=1208) (n=362). Mean age (y) 62 66 Prior MI 40% 47% Heart failure 7% 16% PTCA 31% 28% CABG 23% 24%. 20. 15. 10. 5. 0.
E N D
PRISM-PLUS: Demographics of Patients With Diabetes Patients Without Patients With Diabetes Diabetes (n=1208) (n=362) Mean age (y) 62 66 Prior MI 40% 47% Heart failure 7% 16% PTCA 31% 28% CABG 23% 24%
20 15 10 5 0 PRISM-PLUS: MI/Death Outcomes in Patients With Diabetes P=0.044 P=0.002 19.2% 15.5% P=0.004 11.2% % Patients 9.3% 4.7% 1.2% Day 7 Day 30 Day 180
20 15 10 5 0 PRISM-PLUS: MI in Patients With Diabetes P=0.008 P=0.002 13.5% P<0.001 11.4% % Patients 7.8% 4.7% 1.8% 0% Day 7 Day 30 Day 180
PRISM-PLUS: Results in Patients With Diabetes Conclusion Tirofiban + heparin therapy resulted in a marked sustained reduction in major cardiac outcomes, particularly recurrent MI, in patients with diabetes presenting with UAP/NQWMI.